Your browser doesn't support javascript.
loading
Metabolic Syndrome as a Factor of Impairment of Antioxidant Defense System in Youth with T1DM.
Grabia, Monika; Socha, Katarzyna; Bossowski, Artur; Markiewicz-Zukowska, Renata.
Afiliação
  • Grabia M; Department of Bromatology, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Bialystok, Mickiewicza 2D Street, 15-222 Bialystok, Poland.
  • Socha K; Department of Bromatology, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Bialystok, Mickiewicza 2D Street, 15-222 Bialystok, Poland.
  • Bossowski A; Clinic of Pediatrics, Endocrinology, Diabetology with the Subdivision of Cardiology, Children's University Clinical Hospital in Bialystok, Waszyngtona 17 Street, 15-274 Bialystok, Poland.
  • Markiewicz-Zukowska R; Department of Bromatology, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Bialystok, Mickiewicza 2D Street, 15-222 Bialystok, Poland.
Int J Mol Sci ; 24(11)2023 May 29.
Article em En | MEDLINE | ID: mdl-37298384
Research indicates that adolescents with type 1 diabetes mellitus (T1DM) may develop both metabolic syndrome (MetS) and oxidative stress. The purpose of this study was to test the hypothesis that MetS could potentially affect antioxidant defense parameters. The study recruited adolescents aged 10-17 who had been diagnosed with T1DM, and divided them into two groups: "MetS+" (n = 22), who had been diagnosed with MetS, and "MetS-" (n = 81), who did not have metabolic syndrome. A control group consisting of 60 healthy peers without T1DM was included for comparison. The study examined cardiovascular parameters, such as complete lipid profile and estimated glucose disposal rate (eGDR), as well as markers of antioxidant defense. The results revealed a statistically significant difference between the MetS+ and the MetS- group in terms of total antioxidant status (TAS) (1.186 mmol/L vs. 1.330 mmol/L), and oxidative stress index (OSI) levels (0.666 vs. 0.533). Furthermore, multivariate correspondence analysis identified individuals with HbA1c < 8%; eGDR > 8 mg/kg/min, using either flash or continuous glucose monitoring systems, as MetS- patients. The study also found that eGDR (AUC 0.85, p < 0.001), OSI and HbA1c (AUC 0.71, p < 0.001) markers may be useful for diagnosing the onset of MetS in adolescents with T1DM.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome Metabólica / Diabetes Mellitus Tipo 1 Tipo de estudo: Prognostic_studies Limite: Adolescent / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome Metabólica / Diabetes Mellitus Tipo 1 Tipo de estudo: Prognostic_studies Limite: Adolescent / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article